biotech
Trial failures threaten UK biotech
February 18, 2011Research and Development AML, AS1411, AS1413, Antisoma, Juvista, Renovo, UK biotech, acute myeloid leukaemia, anti-scarring, biotech
A number of late stage failures from British biotech firms have left a looming question mark over the future of …
Pharma-biotech partnerships: creative approaches to doing the deal
January 26, 2011Research and Development Susan Aldridge, biotech, biotech partnerships, pharma partnering
Research and development partnerships between big pharma and the biotech sector are now a vital component in bringing new medicines …
US biotech investment doubles
August 11, 2010Research and Development biotech, funding
Investment in the beleaguered US biotechnology sector shot up in the second quarter of this year, but analysts say it’s …
Mixed reaction for Osborne’s first Budget
June 23, 2010Research and Development, Sales and Marketing biotech, pharma, tax, tax relief
George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
UK to get biotech academy
March 17, 2010Business Services biotech, pharma training, skills
A national biotech academy will be set up in the UK as part of a government plan to ensure that …
Drug development: where’s the added investment value?
February 18, 2010Research and Development CRO, Les Rose, R&D, biotech, funding
Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …
PolyTherics raises £3m to fund PEG expansion
February 17, 2010Manufacturing and Production, Research and Development PolyTherics, biotech, pegylation
UK drug delivery specialist PolyTherics has raised an additional £3 million in funding as it extends the focus of its …
BIA appoints Nigel Gaymond chief executive
December 11, 2009Research and Development BIA, appointment, biotech, research and development
The BioIndustry Association (BIA) has appointed Nigel Gaymond as its new chief executive.
Call for Europe-wide innovation fund
December 3, 2009Research and Development Europe, biotech, finance
A new report on the state of biotech and pharmaceutical R&D in Europe says the sector is suffering from a …
New deal supports French pharma and biotech
December 1, 2009Research and Development, Sales and Marketing France, biotech
The French government has agreed a new deal with industry leaders to help the country’s pharma and biotech industries.President Sarkozy …
Building value – is the pipeline all that matters?
December 1, 2009Research and Development Les Rose, biotech, venture capital
Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …
Whatever happened to yesterday’s ‘magic bullets’?
November 3, 2009Research and Development Les Rose, biotech
How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …
Cambridge biotech – innovation and global partnerships
October 19, 2009Research and Development Cambridge, ERBI, biotech, regenerative medicine
Just two years ago it cost $10m to sequence a human genome, now for $48,000 you can have a personal …
Biotech suffers as recession hits
September 11, 2009Medical Communications biotech, intercytex
The fears of many biotech leaders are being realised, as a string of small-scale companies face liquidation at the hands …
Canada’s biotech challenge
July 27, 2009Research and Development Canada, Transition Therapeutics, biotech, funding
The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
